Israeli Legislation.com
RegulationsHealth

National Health Insurance (Quality Indicators and Disclosure of Information) Regulations, 5772-2012

תקנות ביטוח בריאות ממלכתי (מדדי איכות ומסירת מידע), תשע"ב-2012

Published: 2012-05-10Consolidated Hebrew text as of 2023-09-18 · Last amended 2020-05-21
Premium
Unofficial English translation — for reference only. It may contain errors or omissions and cannot be relied on as a legal text. Only the Hebrew text published in Reshumot is legally binding.More

This English text was translated from the official Hebrew using a range of translation tools, and it undergoes ongoing checks and updates. It is not a certified translation.

Despite these checks, it may contain errors, omissions, or imprecise renderings of legal terminology and cross-references, and it may not yet reflect the latest amendments. It cannot be relied upon as a legal text.

The Hebrew text as published in Reshumot (ספר החוקים) and on the Knesset website is the sole authoritative and legally binding version. In any discrepancy, the Hebrew text prevails.

This translation is provided for informational purposes only and does not constitute legal advice. For use in legal proceedings, request a certified Expert Legal Opinion.

By virtue of my authority under Sections 35 and 60(a) of the National Health Insurance Law, 5754-1994, and Section 29a(1) of the Public Health Ordinance, 1940, I hereby promulgate the following Regulations:

Definitions§

1.

In these Regulations –

"advisory committee" – a committee appointed by the Government Physician pursuant to regulation 5;

"quality indicator" – an indicator that represents, in a reliable and valid manner, directly or indirectly, in an outcome or process value, the scope or the level of quality of medical treatment or of health services in hospitals and in health funds, according to the subjects set out in the Schedule;

"the Government Physician" – the Director General of the Ministry of Health.

Definition of Quality Indicators§

2.

The Government Physician, after consulting the advisory committee, shall define the quality indicators according to the subjects set out in the Schedule and shall publish them on the Ministry of Health website at www.health.gov.il (hereinafter – the Ministry of Health website).

Obligation to Disclose Information§

3.
(a)The director of a hospital or the director of a health fund, or a person appointed by them for that purpose, shall be required to provide the Government Physician with any administrative, financial or medical information that the Government Physician may require, which is necessary for the purpose of measuring medical treatment or health services in relation to the quality indicators (hereinafter – the measurement), at the time and in the manner that the Government Physician shall direct for each hospital and each health fund.
(b)Information required pursuant to sub-regulation (a) that relates to a patient on an individual basis shall include personal data of the patient as the Government Physician shall direct, which shall not be such as to lead to the identification of the patient, in accordance with the coding and encryption method directed by the Government Physician, after consulting the Registrar of Databases appointed pursuant to the Privacy Protection Law, 5741-1981, whilst implementing technological means whose purpose is to minimise the risk of misuse or of harm to information stored in the system.

Analysis of Information§

4.
(a)The Government Physician shall analyse the information received as stated in regulation 3 and shall transmit the findings to the advisory committee in a manner that does not identify a treating practitioner, a patient, a hospital or a health fund.
(b)Notwithstanding the provisions of sub-regulation (a), where a hospital, a health fund or a treating practitioner is the sole provider in the country of the service or medical treatment being measured, the Government Physician shall be entitled to transmit the findings of the measurement to the committee even if the findings may lead to their identification; if any member of the advisory committee is liable to be in a position of personal or institutional conflict of interest in relation to the matter under discussion, that member shall notify the chairperson of the advisory committee accordingly and shall act in accordance with the chairperson's directions, in consultation with the legal adviser of the Ministry of Health.

Appointment of an Advisory Committee and Its Functions§

5.
(a)The Government Physician shall appoint an advisory committee whose permanent members shall be as follows:
(1)the Head of the Medical Administration in the Ministry of Health, who shall serve as chairperson of the committee;
(2)the Deputy Director General of the Ministry of Health;
(3)the Head of the Nursing Administration in the Ministry of Health;
(4)the Head of the Information Division of the Ministry of Health;
(5)a representative of the Quality Administration in the Ministry of Health;
(6)the Chief Scientist of the Ministry of Health;
(7)an academic representative;
(8)two representatives from health funds;
(9)two representatives from hospitals that are not owned by health funds.
(b)The advisory committee may invite experts to its deliberations, as it sees fit.
(c)The advisory committee shall advise the Government Physician on the definition of quality indicators as stated in regulation 2 and on the definition of information required for the purpose of the measurement as stated in regulation 3.
(d)The advisory committee shall deliberate on the findings of the measurement transmitted to it by the Government Physician as stated in regulation 4 and may, insofar as it sees fit, recommend to the Government Physician that the information received as stated in regulation 3 be analysed in a different manner.

Publication of Measurement Findings§

6.
(a)The Government Physician shall publish, from time to time, the findings of the measurement in respect of hospitals and health funds on the Ministry of Health website and by additional means that will ensure the availability of the information and its accessibility to the general public.
(b)Publication of the findings of the measurement shall be in a manner that identifies the entity to which the findings relate.
(c)Notwithstanding the provisions of sub-regulation (a), the Government Physician shall not publish measurement findings if satisfied, after consulting the advisory committee, that it has not been established that they reliably reflect the indicator that was defined or that they have not been scientifically proven.
(d)Notwithstanding the provisions of sub-regulation (b), the Government Physician may publish the findings of the measurement in a manner that does not identify the entity to which the findings relate if satisfied, after consulting the advisory committee, that there is a concern that their publication in an identifying manner may endanger public safety.

Right to Be Heard§

7.
(a)Prior to the publication of the findings of the measurement in a manner that identifies the entity to which the findings relate, the Government Physician shall transmit them to the entity to which the findings relate, together with a written notice of the Government Physician's intention to publish them and of that entity's right to present to the Government Physician, in writing within 14 days, data and arguments that are capable of affecting the measurement findings that the Government Physician intends to publish.
(b)An entity to which the Government Physician has transmitted the findings of the measurement as stated in sub-regulation (a) shall not publish the findings transmitted to it prior to their publication by the Government Physician.
(c)The Government Physician shall examine the arguments of the entity transmitted to the Government Physician as stated in sub-regulation (a), and for that purpose the Government Physician may consult the advisory committee subject to the provisions of regulation 4; the Government Physician shall notify the entity of the decision and shall not publish the findings before 45 days have elapsed from the date of the written notice given to that entity of the rejection of its objection to publication.
(d)If a response as stated in sub-regulation (a) has not been received within 14 days, the Government Physician may publish the findings of the measurement in a manner that identifies the entity to which the findings relate as stated in regulation 6(a) and (b).

Commencement§

8.

The commencement of these Regulations is 90 days from the date of their publication.

Schedule (regulation 1)

The following subjects – general information may be required in respect of them and detailed information may be required in respect of them according to patient characteristics:

1.§

Outcomes of medical treatment – including treatment successes, complications and side effects;

2.§

Medical treatment processes – including medical documentation, diagnostic accuracy, administration of medications, medical interventions and compliance with procedures;

3.§

Frequency of medical diagnoses, test results and the quality of the diagnostic level;

4.§

The level of investment in treatment safety, reporting of exceptional incidents, management of review committees, conducting of debriefings for learning from exceptional incidents, the manner of managing an exceptional incident, investment in infrastructure and structure;

5.§

Availability and use of medical infrastructure, including human resources, medical equipment, use of technologies, medical apparatus and computing;

6.§

Service indicators in medical treatment, use of technologies to improve the service, and patient experience and patient satisfaction.

RegulationsHealth

תקנות ביטוח בריאות ממלכתי (מדדי איכות ומסירת מידע), תשע"ב-2012

National Health Insurance Quality Indicators Regulations

Health Insurance Quality Indicators Disclosure

Takkanot Bittuach Briyut Medinati

NHI Quality Indicators Regulations

Health insurance quality standards Israel

Medical quality disclosure regulations

Healthcare provider quality metrics

Kupat Cholim quality disclosure

Israeli health insurance transparency law

Quality indicators health insurance 2012